Global Autoimmune Disease Diagnosis Market Overview
Autoimmune diseases is defined as body’s abnormal immune response resulting to production of antibodies that attack own cells and tissues, leading to destruction and deterioration of healthy tissues. There are nearly 80 types of prevailing autoimmune diseases globally including systemic rheumatoid arthritis or lupus erythematosus. According to the data published by American Autoimmune Related Diseases Association (AARDA), autoimmune disease infects nearly 50 million Americans and 75% of them are females. The tests recommended to diagnose the autoimmune disease include auto antibody test, complete blood count, antinuclear antibody test, C-reactive protein, and erythrocyte sedimentation rate.Autoimmune Disease Diagnosis Market xx was valued at US$ Xx Billion in 2024 and is projected to grow at a CAGR of xx% to reach US$ xx Billion by 2034.
Global Autoimmune Disease Diagnosis Market Dynamics
Growing awareness about autoimmune diseases
Growing awareness about autoimmune diseases through programs of education, research, support, and advocacy is a key factor driving the utilized rates of autoimmune disease diagnostics, worldwide. The U.S. has the highest prevalence’s of autoimmune diseases, whereas around 50 million patients suffer from autoimmune diseases. According to study reported by Arthritis Foundation, in 2017 nearly 54.4 million adults in the U.S. suffer from diagnosed arthritis. According to the International Diabetes Federation (IDF) report of the 2017, around 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number might increase to 629 million, across the globe. NGOs and government organizations aims to increase awareness about the socioeconomic impact of autoimmunity by driving and facilitating collaboration in the areas of education, research, public awareness, and patient services in an ethical, efficient, and effective manner. The other factors, such as partnerships with physicians and clinical laboratories, improved laboratory automation, and technological advancements, are fueling the autoimmune disease diagnostics market.
Increasing collaboration between market players
The growing partnerships between companies involved in autoimmune disease diagnostics market is useful for technology transfer, thereby increasing the availability of diagnostic systems. For example in 2015, Sengenics acquired Oxford Gene Technology’s protein array technology. This acquisition was useful in the diagnosis of various autoimmune conditions.
However, high costs associated with procurement and use of technologically advanced diagnosis tools for autoimmune diseases is a major factor hampering growth of the autoimmune disease diagnosis market. Further, growing competition among prominent players and complex regulatory framework in the market is limiting the market in a negative way, which is anticipated to restrain growth of the autoimmune disease diagnosis market to a certain extent.
Global Autoimmune Disease Diagnosis Market Segmentation
Autoimmune disease diagnosis market is segmented based on product, test type, disease, end-user, and region.
On the basis of product, the autoimmune disease diagnosis market is segmented into consumables & assay kits and instruments. Based on test type, the target market is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic test, and other tests. Based on disease, the target market is segmented into rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. Based on end-user, the target market is segmented into clinical laboratories, hospitals, and other end users.
Regional Insights:
On region the autoimmune disease diagnosis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America account the highest market share of over 40.0% in 2016, mainly due to the presence of favorable regulations & initiatives undertaken by the AARDA, launch of the Affordable Care Act, and high prevalence of disease in the region. Asia Pacific region is anticipated to register lucrative growth owing to growing patient awareness levels, continuously improving healthcare infrastructure, and presence of high unmet patient needs. It is projected to experience a growth in revenue share in the coming years.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2025 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2025 |
|
Market Segmentation |
By Product type - Consumables & Assay Kits and Instruments By Test Type– Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, and Other Tests By Disease– Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases By End-user– Clinical Laboratories, Hospitals, and Other End Users |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest application trends and opportunities in each of the sub-segments from 2019 to 2025. For the purpose of this study, has segmented the autoimmune disease diagnosis market report based on product, test type, disease, end-user, and region.
Autoimmune Disease Diagnosis Market, By Product:
- Consumables & Assay Kits
- Instruments
Autoimmune Disease Diagnosis Market, By Test Type:
- Routine Laboratory Tests
- Inflammatory Markers
- Autoantibodies & Immunologic Test
- Other Tests
Autoimmune Disease Diagnosis Market, By Disease:
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjögren’s Syndrome
- Thyroiditis
- Scleroderma
- Other Diseases
Autoimmune Disease Diagnosis Market, By End-user:
- Clinical Laboratories
- Hospitals
- Other End Users
Autoimmune Disease Diagnosis Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Autoimmune Disease Diagnosis Market Key Players
The key players operating the autoimmune disease diagnosis market includes Thermo Fisher Scientific, Siemens Healthcare Private Limited, Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics Inc., Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Bio-Rad Laboratories, Inc. Development of novel products for rapid and efficient diagnosis is key strategy adopted by majority of key players. For instance, in January 2002, Siemens Healthiness launched ACUSON Redwood Ultrasound System at IRIA 2020 in India. This launched enabled advanced applications precise lesion detection and characterization. Further, AI-powered tools help reduce exam burden and increase efficiency, Lightweight. Portable design permits easy transport and use across clinical departments.
Global Autoimmune Disease Diagnosis Market Company Profile
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hoffmann-La Roche Ltd.
- Siemens Healthcare Private Limited
- Abbott Laboratories
- Beckman Coulter, Inc.
- SQI Diagnostics Inc.
- Quest Diagnostics
- EUROIMMUN AG
- INOVA Diagnostics, Inc.
- Bio-Rad Laboratories, Inc.
Global Autoimmune Disease Diagnosis Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Autoimmune Disease Diagnosis Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Test Type
- Market Snippet, By Disease
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product, 2020 – 2025, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2025
- Y-o-Y Growth Analysis (%), 2020 – 2025
- Segment Trends
- Consumables & Assay Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Overview
- Market Segmentation, By Test Type, 2020 – 2025, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2025
- Y-o-Y Growth Analysis (%), 2020 – 2025
- Segment Trends
- Routine Laboratory Tests
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Inflammatory Markers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Autoantibodies & Immunologic Test
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Other Test
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Overview
- Market Segmentation, By Disease, 2020 – 2025, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2025
- Y-o-Y Growth Analysis (%), 2020 – 2025
- Segment Trends
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Systemic Lupus Erythematosus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Sjögren’s Syndrome
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Thyroiditis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Scleroderma
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Overview
- Market Segmentation, By End-user, 2020 – 2025, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2025
- Y-o-Y Growth Analysis (%), 2020 – 2025
- Segment Trends
- Clinical Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2025
- Overview
- Global Market, By Region, 2020 – 2025, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2025
- Y-o-Y Growth Analysis (%), 2020 – 2025
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Test Type, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2025
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2025
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Test Type, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2025
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2025
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Test Type, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2025
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2025
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Test Type, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2025
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2025
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Test Type, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Disease, 2020 – 2025
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2025
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2025
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Hoffmann-La Roche Ltd.
- Siemens Healthcare Private Limited
- Abbott Laboratories
- Beckman Coulter, Inc.
- SQI Diagnostics Inc.
- Quest Diagnostics
- EUROIMMUN AG
- INOVA Diagnostics, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Autoimmune disease diagnosis market is segmented based on product, test type, disease, end-user, and region.
Growing awareness about autoimmune diseases through programs of education, research, support, and advocacy is a key factor driving the utilized rates of autoimmune disease diagnostics, worldwide.
North America account the highest market share of over 40.0% in 2016, mainly due to the presence of favorable regulations & initiatives undertaken by the AARDA, launch of the Affordable Care Act, and high prevalence of disease in the region.
The key players operating the autoimmune disease diagnosis market includes Thermo Fisher Scientific, Siemens Healthcare Private Limited, Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics Inc., Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Bio-Rad Laboratories, Inc.